187 related articles for article (PubMed ID: 29308562)
1. Connection between Parameters of Erythron System and Myelofibrosis during Chronic Myeloleukemia, Multiply Mieloma, and Chronic Lymphatic Leukemia.
Dolgikh TY; Sholenberg EV; Kachesov IV; Senchukova SR
Bull Exp Biol Med; 2018 Jan; 164(3):382-385. PubMed ID: 29308562
[TBL] [Abstract][Full Text] [Related]
2. Specific Features of Interactions between Megakaryocytic and Granulocytic Hematopoiesis Lineages and Myelofibrosis during the Acute Phase of Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Dolgikh TY; Senchukova SR; Vinogradova EV; Krinitsyna YM
Bull Exp Biol Med; 2020 Apr; 168(6):734-738. PubMed ID: 32333309
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Myelofibrosis in Chronic Myeloid Leukemia, Multiple Myeloma, and Chronic Lymphoid Leukemia during Various Phases of Diseases.
Dolgikh TY; Domnikova NP; Tornuev YV; Vinogradova EV; Krinitsyna YM
Bull Exp Biol Med; 2017 Feb; 162(4):483-487. PubMed ID: 28239786
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Analysis of Red Bone Marrow Microenvironment Cells in Patients with Chronic Myeloid Leukemia, Multiple Myeloma, and Chronic Lymphocytic Leukemia in the Dynamics of Chemotherapy.
Dolgikh TY; Kachesov IV; Tornuev VV; Vinogradova EV; Krinitsyna YM
Bull Exp Biol Med; 2018 Oct; 165(6):786-789. PubMed ID: 30353331
[TBL] [Abstract][Full Text] [Related]
5. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
[TBL] [Abstract][Full Text] [Related]
6. Therapy-related changes of CD34+ progenitor cells in chronic myeloid leukemia: a morphometric study on sequential trephine biopsies.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Goekce D; Diehl V; Zankovich R; Schaefer HE
J Hematother Stem Cell Res; 2001 Dec; 10(6):827-36. PubMed ID: 11798509
[TBL] [Abstract][Full Text] [Related]
7. Morphometric analysis of myelofibrosis in agnogenic myeloid metaplasia and chronic myelogenous leukemia.
Ohsaka A; Miura Y; Takahashi A; Yokoyama T
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(6):399-405. PubMed ID: 1683056
[TBL] [Abstract][Full Text] [Related]
8. The role of beta-catenin in chronic myeloproliferative disorders.
Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic management of hematological malignancies in elderly patients. Biological and clinical considerations. Part III: The chronic leukemias and myelofibrosis.
Quaglino D; Di Leonardo G; Furia N; Pasqualoni E; Campitelli A
Aging (Milano); 1997 Dec; 9(6):383-90. PubMed ID: 9553616
[TBL] [Abstract][Full Text] [Related]
10. Grading of marrow fibrosis in chronic myeloid leukemia--a comprehensive approach.
Rao S; Sen R; Singh S; Ghalaut PS; Arora BB
Indian J Pathol Microbiol; 2005 Jul; 48(3):341-4. PubMed ID: 16761746
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.
Bouchnita A; Eymard N; Moyo TK; Koury MJ; Volpert V
Am J Hematol; 2016 Jun; 91(4):371-8. PubMed ID: 26749142
[TBL] [Abstract][Full Text] [Related]
12. Platelet derived growth factor expression, myelofibrosis and chronic myelogenous leukemia.
Kimura A; Katoh O; Hyodo H; Kuramoto A; Satow Y
Leuk Lymphoma; 1995 Jul; 18(3-4):237-42. PubMed ID: 8535188
[TBL] [Abstract][Full Text] [Related]
13. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
Thiele J; Kvasnicka HM; Beelen DW; Flucke U; Spoer C; Paperno S; Leder LD; Schaefer UW
Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
[TBL] [Abstract][Full Text] [Related]
14. [Pathological characteristics of leukemia patients with secondary myelofibrosis and their relationship with the prognosis of disease].
Guan JH; Wang XN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):311-4. PubMed ID: 23628022
[TBL] [Abstract][Full Text] [Related]
15. Chronic myeloid leukaemia masquerading as primary myelofibrosis.
Mohamed M; Beamish M; Grabek J
Pathology; 2014 Jan; 46(1):75-7. PubMed ID: 24300731
[No Abstract] [Full Text] [Related]
16. Histo- and immunomorphometry of megakaryopoiesis in chronic myeloid leukemia with myelofibrosis and so-called primary (idiopathic) osteo-myelofibrosis/-sclerosis.
Thiele J; Steinberg T; Hoeppner B; Wienhold S; Wagner S; Dienemann D; Fischer R
Anal Cell Pathol; 1990 Jul; 2(4):215-27. PubMed ID: 2275869
[TBL] [Abstract][Full Text] [Related]
17. Clinical Morphological Studies of Myelofibrosis with Different Types of Bone Marrow Involvement in Patients with Chronic Lymphocytic Leukemia.
Dolgikh TY; Sholenberg EV; Kachesov IV; Domnikova NP; Klinnikova MG
Bull Exp Biol Med; 2016 Jul; 161(3):408-11. PubMed ID: 27496034
[TBL] [Abstract][Full Text] [Related]
18. Spred2 modulates the erythroid differentiation induced by imatinib in chronic myeloid leukemia cells.
Yang Y; Liu X; Xiao F; Xue S; Xu Q; Yin Y; Sun H; Xu J; Wang H; Zhang Q; Wang H; Wang L
PLoS One; 2015; 10(2):e0117573. PubMed ID: 25688862
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1 alpha in the pathogenesis.
Kimura A; Hyodo H; Nakata Y; Kuramoto A
Am J Hematol; 1993 May; 43(1):47-50. PubMed ID: 8317461
[TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma and chronic leukaemias in 2014: improved understanding of disease biology and treatment.
San-Miguel JF; Kantarjian HM
Nat Rev Clin Oncol; 2015 Feb; 12(2):71-2. PubMed ID: 25511190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
